Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Hemabate

Generic name: Carboprost tromethamine

FDA application holder: Pfizer

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Hemabate?
Hemabate is a brand name of Carboprost tromethamine, a prescription medicine. The FDA NDC Directory lists 1 Hemabate product in 1 strength and form.
Who makes Hemabate?
Pfizer holds the FDA application for Hemabate (NDA017989, approved January 9, 1979).
Is there a generic or store brand of Hemabate?
Yes. The FDA NDC Directory lists 20 other products with the same active ingredients, strength and form as a Hemabate product, 20 of them generic. Ask your pharmacist whether one is right for you.
Has Hemabate been recalled?
No recall linked to Hemabate products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Hemabate is

Each Hemabate product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Carboprost tromethamine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
carboprost tromethamine 250 ug/mL
injection, solution (intramuscular)
Hemabate 20 products, 18 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Carboprost tromethamine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Hemabate products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA017989PfizerJanuary 9, 19791

Companies that list Hemabate

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Hemabate products.

Recalls

No recall linked to Hemabate products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers